wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38672084-F6AADF83-C39D-40CF-9FCF-DE00C66CF65B
Q38672084-F6AADF83-C39D-40CF-9FCF-DE00C66CF65B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38672084-F6AADF83-C39D-40CF-9FCF-DE00C66CF65B
Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy.
P2860
Q38672084-F6AADF83-C39D-40CF-9FCF-DE00C66CF65B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38672084-F6AADF83-C39D-40CF-9FCF-DE00C66CF65B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d92c8fcb316081b4a64b9791e02a76343964c822
P2860
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.